NeuroOne Medical Technologies Corporation Share Price Other OTC
Equities
NMTC
US64130M1009
Advanced Medical Equipment & Technology
Sales 2022 | 2.12 176.52 | Sales 2023 | 3.41 283.72 | Capitalization | 21.3M 1.77B |
---|---|---|---|---|---|
Net income 2022 | -10M -833M | Net income 2023 | -11M -916M | EV / Sales 2022 | 77,61,717 x |
Net cash position 2022 | 10.94M 911M | Net cash position 2023 | 5.14M 428M | EV / Sales 2023 | 47,42,168 x |
P/E ratio 2022 |
-2.7
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.85% |
Latest transcript on NeuroOne Medical Technologies Corporation
Managers | Title | Age | Since |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 20/09/20 |
David Rosa
CEO | Chief Executive Officer | 59 | 20/17/20 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 04/17/04 |
Director/Board Member | 63 | 04/17/04 | |
Edward Andrle
BRD | Director/Board Member | 66 | 18/20/18 |
1st Jan change | Capi. | |
---|---|---|
-42.33% | 2.95B | |
+19.36% | 1.88B | |
-1.05% | 1.63B | |
+33.96% | 1.34B | |
-16.83% | 959M | |
-21.96% | 888M | |
+7.07% | 842M | |
-27.07% | 623M | |
+10.85% | 513M |